To join the meeting online please click on the bottom below:

PROGRAM

9:30 – 9:50
Introduction
Prof. em. Dr. Dr. h.c. mult. Roland Mertelsmann, Prof. Dr. Joschka Boedecker, CRIION Freiburg, Germany

9:50 – 9:55
Welcome remarks from Baden-Württemberg
Nadyne Saint-Cast, MdL, die Grünen

10:00 – 10:00 Welcome remarks from the University Hospital of Freiburg
Chief Medical Director Prof. dr. Dr. h.c. Frederik Wenz

10:00 – 10:05 Welcome remarks from the Technical Faculty of Freiburg University

10:05 – 10:35
Interpretability, efficency, accessibility & trustworthiness: Building the foundations of applicable AI in oncology
Dr. Maria Kalweit, CRIION, Freiburg, Germany

Coffee break

Session 1: Understanding Cancer Through AI and Computational Biology
This session will explore how AI and computational biology can improve our understanding of cancer.
Chair: Prof. Dr. Robert Zeiser, Univerisity of Freiburg, Germany, Prof. Dr. Adriana Tomic, Boston University, USA

11:00 – 11:30
Knowledge-based machine learning to extract disease mechanisms from multi-omics data
Prof. Julio Saez-Rodriguez, Universität Heidelberg, Germany

11:30 – 12:00
Improving cell segmentation in spatial transcriptomics
Dr. Daniel Jones, Fred Hutch Cancer Center, USA

12:00 – 12.30
Exploring mechanisms and functional heterogeneity in cellular immunotherapies targeting cancer via machine learning analysis of live-imaging
Dr. Maria Alieva, Instituto de Investigaciones Biomédicas de Madrid, Spain

12:30 – 12:40
Best Abstract Award

Lunch break & Poster Presentation

Session 2: Building Trust and Regulation in Artificial Intelligence Models for Medicine
This session will examine how to incorporate trust and regulatory to the development and deployment of AI and computational biology-powered cancer therapies.
Chair: Prof. Dr. Joschka Boedecker, Univerisity of Freiburg, Germany, Dr. Jan Moritz Middeke, University Hospital Dresden, Germany

13:40 – 14:10
New regulatory thinking is needed for ‘at-the-patient-bedside’ AI-based personalised drug and cell therapies in precision oncology
Prof. Steven Gilbert, Technische Universität Dresden, Germany

14:10 – 14:40
An instrument like any other? Ethical considerations on the use of AI in medicine
Dr. Markus Herrmann, NCT Heidelberg, Germany

14:40 – 15.10
A regulator’s perspective on AI-based indications for anti-cancer medicines
Dr. Harald Enzmann, BFARM, Germany

15:10 – 15:20
Best Abstract Award

Coffee break

Session 3: Deploying AI and Computational Biology into Clinical Applications
In this session, speakers will discuss the challenges and opportunities of translating AI and computational biology into clinical practice for cancer diagnosis, prognosis, and treatment.
Chair: Prof. Dr. Melanie Börries, University of Freiburg, Germany, Prof. Dr. Christoph Merten, EPFL, Switzerland,

15:50 – 16:20
The practical usage of AI Applications in routine diagnostics
Sven Maschek, MLL Münchner Leukämieabor, Germany

16:20 – 16.50
AI for better cancer care
Dr. Andre Dekker, Maastricht University Medical Center, Netherlands

16:50 – 17:20
Machine learning for personalized cancer care
Prof. Adam Yala, Berkeley, USA

17:20 – 17:30
Best Abstract Award

17:30 – 17:40
Audience Abstracts Award

17:40 – 17:50
Closing remarks
Prof. Dr. Evelyn Ullrich, Goethe University, Ullrich Lab Frankfurt, Germany

Networking Apéro